baber/WOPTO huggingface dataset:
Patent EP-1780413-A2 (EP)
Inventor: SUZUKI HISASHI
IPC: F04B27/10
Filed: 2006-10-24
Abstract: A swash plate compressor is provided with first conducting means conductive to a shoe 22 of a piston 20 and second conducting means conductive to a swash plate 30, a voltage with a predetermined intensity is applied from the outside to each of the shoes 22 and the swash plate 30 by a voltage application circuit 54, and a voltage value of the voltage application circuit 54 is measured by a voltage measuring instrument 55 so that a failure in oil film formation between the shoe 22 and the swash plate 30 can be detected. Thus, there is no need to install precision equipment such as a sensor, a camera or a transmitter inside the compressor body 10, and the failure in oil film formation can be detected more surely with a simple structure.
Patent EP-1811364-A2 (EP)
Inventor: CZAYA CLAUS-PETER
IPC: G06F3/045
Filed: 2006-11-24
Abstract: The device (1) has a contact-sensible surface with a resistive layer arrangement (2), a capacitive layer arrangement (3), a resistively evaluable layer structure and a capacitively evaluable layer structure for determination of a position of an object e.g. fingers, that contacts the surface or stays before contacting the surface. The arrangements and the structures allow capacitive and resistive evaluations. The capacitive layer arrangement lies above the resistive layer arrangement.
Patent EP-1691235-A2 (EP)
Inventor: LEE WAI HON
IPC: B29D11/00
Filed: 2006-02-13
Abstract: A Fresnel lens of the prior art is split into two Fresnel lenses to allow easier control of the horizontal and vertical viewing angles. In a second embodiment, the Fresnel lens is entirely eliminated. Instead, the diffuser contains elliptical microstructures so that the diffusing cones in orthogonal directions are different, eliminating the need for a Fresnel lens to perform this function. To compensate for the absence of the light collimation provided by the Fresnel lens, a diffuser with spatially varying diffusing angles is used.
Patent EP-1707981-A2 (EP)
Inventor: KOJIMA HARUO
IPC: G01S7/03
Filed: 2006-03-28
Abstract: A transmitter-receiver module includes a first amplifier, a second amplifier, a detection unit, and a control unit. The first amplifier is configured to amplify a transmitter signal, the second amplifier is configured to amplify a receiver signal, the detection unit is configured to detect the receiver signal amplified by the second amplifier, and the control unit is configured to control the first amplifier so as to reduce a level of the signal from the first amplifier when the signal detected by the detection unit exceeds a predetermined level.
Patent EP-1742123-A2 (EP)
Inventor: TOTH CARL RAYMOND
IPC: G05B9/03
Filed: 2006-06-26
Abstract: A redundant control system (10) including at least three redundant signals (12a-c) is presented. The redundant control system (10) includes a failure circuit (14) associated with each of the redundant signals (12a-c). The failure circuit (14) generates a failure signal (24) in response to an occurrence of a failure of a corresponding one of the redundant signals (12a-c). A select circuit is associated with each of the redundant signals (12a-c). The select circuit is receptive to a default signal associated with the corresponding one of the redundant signals (12a-c), to the failure signal (24), and to the corresponding one of the redundant signals (12a-c). The select circuit selects the default signal when the failure signal (24) indicates a failure of the corresponding one of the redundant signals (12a-c) and selects the corresponding one of the redundant signals (12a-c) when the failure signal (24) does not indicate a failure for the corresponding one of the redundant signals (12a-c). A median determination circuit (30) is receptive to the default signals selected and the redundant signals selected to determine a median signal (38) indicative of a median of the default signals selected and the redundant signals (12a-c) selected.
Patent EP-1753018-A2 (EP)
Inventor: YANG JONG IN
IPC: C30B29/40
Filed: 2006-07-24
Abstract: A method for manufacturing a nitride based single crystal substrate and a method for manufacturing a nitride based semiconductor device. The method for manufacturing the nitride based single crystal substrate includes forming a nitride based single crystal layer on a preliminary substrate; forming a polymer support layer by applying a setting adhesive material having flowability on the upper surface of the nitride based single crystal layer and hardening the applied adhesive material; and separating the nitride based single crystal layer from the preliminary substrate by irradiating a laser beam onto the lower surface of the preliminary substrate. The method for manufacturing the nitride based single crystal substrate is applied to the manufacture of a nitride based semiconductor device having a vertical structure.
Patent EP-1780319-A2 (EP)
Inventor: FUJISAWA SHIGENOBU
IPC: D21F1/00
Filed: 2006-10-27
Abstract: An industrial two-layer fabric having a lower surface structure excellent in water drainage property, fiber supporting property, rigidity and wear resistance, obtained by binding an upper layer fabric and a lower layer fabric, wherein each of lower surface side wefts has a design in which it passes over one lower surface side warp, passes under one lower surface side warp, passes over one lower surface side warp and then passes under five successive lower surface side warps, while lower surface side warps each has a design in which it passes over four successive lower surface side wefts, passes under one lower surface side weft, passes over three successive lower surface side wefts, passes under one lower surface side weft, passes over two successive lower surface side wefts, passes under one lower surface side weft, passes over three successive lower surface side wefts and then passes under one lower surface side weft.
Patent EP-1797809-A2 (EP)
Inventor: OH JANG-KEUN
IPC: A47L9/16
Filed: 2006-07-21
Abstract: A robot cleaner (10) that has a dust collection unit (100) with a cyclone part (116) generating an ascending rotary air current from the dust-laden air being drawn in through a lower part thereof, separating the dust from the air using a centrifugal force, and discharging the dust-separated air to the lower part through a center part, and a collection part (113) surrounding the cyclone part (116) to receive the dust being centrifugally separated.
Patent EP-1785572-A2 (EP)
Inventor: MARTIN LOPEZ ANTONIO
IPC: G07F9/06
Filed: 2006-11-14
Abstract: The invention relates to a locking device for public telephone strongboxes installed in a strongbox (1) which does not outwardly show any type of mechanism corresponding to its locking or to its hinging, the real locking mechanism being carried out in a gearmotor (6) transmitting its rotational movement to a shaft (12) acting on a catch (14) that is able to project to the outside a series of balls (15) acting as blocking means on a locking part (17) joined to the inner face of the door (2), such that when the gearmotor (6) rotates in one direction the door is blocked in a locked situation, whereas when it rotates in the opposite direction the balls (15) retract allowing the release of the locking part (17) and are retained in their housings by the axial movement of a retaining ring (18) that can be moved by a spring (19), the hinges (26) are assembled on complementary hooks (24) and stops (25) that are also hidden, such that in the locked situation the door (2) is fixed in four points that cannot be detected from the outside and are virtually impossible to force.
Patent EP-1855678-A2 (EP)
Title: Utilisation d'octanes 2-(diphenylmethy)-1-azabicyclo 2.2.2 - 3-substitues dans le traitement des maladies induites par le recepteur mrg-x1
Inventor: KUNAPULI PRIYA
IPC: A61K31/44
Filed: 2006-01-03
Abstract: L'invention concerne une méthode de traitement d'une maladie ou d'un état induit par le récepteur MRG-X1 humain, tel(le) que la nociception, l'hyperalgie, l'allodynie, la douleur liée aux états d'hypersensibilité centrale, la douleur somatique, la douleur viscérale, la douleur aiguë, la douleur chronique, la douleur postopératoire, les céphalées, la douleur inflammatoire, la douleur neurologique, la douleur musculo-squelettique, la douleur liée au cancer ou la douleur vasculaire, chez un patient humain. Cette méthode consiste à administrer au patient une quantité thérapeutiquement efficace d'un octane 2-(diphénylméthy)-1-azabicyclo[2.2.2]-3-substitué ou d'un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également l'utilisation de ces composés en tant qu'instruments moléculaires permettant d'étudier directement le rôle du récepteur MRG-X1 dans la perception de la douleur.
Patent EP-1833475-A2 (EP)
Inventor: SERHAN CHARLES N
IPC: A61K31/232
Filed: 2006-01-06
Abstract: D'une manière générale, agents thérapeutiques isolés, appelés résolvines, issus de l'interaction des substances suivantes : acide gras oméga 3 polyinsaturé alimentaire du type acide éicosapentanoïque ou docosahexaénoïque, oxygénases, et aspirine analgésique. De façon surprenante, l'isolation soigneuse de composés issus de cette interaction dans un environnement approprié, donne des dérivés dihydroxy et trihydroxy de composés contenant les deux acides susmentionnés, à propriétés structurelles et physiologiques uniques. On décrit donc de nombreux dérivés de ce type, utiles sur le plan thérapeutique (résolvines de série E et D), qui atténuent, préviennent ou traitent les affections gastro-intestinales, par exemple du type colite. On décrit enfin des procédés d'utilisation, des procédés d'élaboration et des produits pharmaceutiques conditionnés destinés à être utilisés comme médicaments, correspondant aux composés considérés.
Patent EP-1846009-A2 (EP)
Inventor: PETERS TOR
IPC: A61K9/70
Filed: 2006-02-13
Abstract: La présente invention concerne un dispositif de traitement thérapeutique, qui comprend un composé, lequel comprend un médicament et un polymère éluant l'oxyde nitrique (NO) agencé de façon à entrer en contact avec un site de traitement dans un organisme ou sur un organisme. Ce dispositif agit comme un accélérateur de timbre éluant un médicament, par exemple des produits pharmaceutiques, des vitamines, de la nicotine, de la nitroglycérine, par lequel des traitements thérapeutiques de valeur importante sont combinés avec profit dans un traitement. Un effet synergique est obtenu par ce dispositif car le NO élué à partir de ce dispositif accélère l'effet du médicament, car le site de traitement est plus sensible à ce médicament par l'effet du NO élué.
Patent EP-1989853-A2 (EP)
Inventor: HEUTSCHI WALTER
IPC: H04W4/24
Filed: 2006-02-23
Abstract: The invention relates to a method and system for one-way or two-way end-to-end data transmissions in heterogeneous networks (30/31/32), an IMSI stored on a SIM card (401/411) of the IP network node (40/41) being transmitted to a register module (22) during a transmission of a data and/or multimedia stream. The IP data channel is complemented to signal and data channels of a GSM network by means of a signaling gateway module (20) and, based on the correspondingly complemented GSM data, the required SS7/MAP functions are generated, the register module (22) executing an authentification of the IP network node (40/41) based on the IMSI at a HLR/VLR/AuC (26) and the data transmission being established to the desired network nodes by means of a control module (21) of the main connection unit (10) when the authentification is successful. The system and method relates in particular to a switching system for IP-based telephony and videoconferencing.
Patent EP-1875197-A2 (EP)
Inventor: NERIN PHILIPPE
IPC: G01N15/02
Filed: 2006-04-14
Abstract: The invention concerns a device (DA) for analyzing microscopic elements, comprising firstly a measuring space (CM) for microscopic elements to be analyzed, secondly at least one source (S) delivering conjugated rays at the measuring space (CM), having at least two different analyzing wavelengths and designed to interact with the microscopic elements in the measuring space (CM) to form interacting rays, thirdly coding means (M) for encoding the rays upstream of the measuring space (CM) with different codes, fourthly optical filtering means (FO) for selectively filtering the interacting rays of fluorescence and/or diffusion depending on their wavelength, fifthly detecting means (DE, DF) for transforming into electric signals part at least of the interacting rays from the measuring space (CM), and sixthly analyzing means (MA) including decoding means (DRE, DRF) for decoding the electric signals to enable data representing the analyzed microscopic elements to be determined.
Patent EP-1872232-A2 (EP)
Inventor: SEINFELD MARC E
IPC: G06F21/56
Filed: 2006-04-20
Abstract: In accordance with the present invention, a system, method, and computer-readable medium for identifying malware in a request to a Web service is provided. One aspect of the present invention is a computer-implemented method for protecting a computer that provides a Web service from malware made in a Web request. When a request is received, an on-demand compilation system compiles high-level code associated with the request into binary code that may be executed. However, before the code is executed, antivirus software designed to identify malware scans the binary code for malware. If malware is identified, the antivirus software prevents the binary code associated with the request from being executed.
Patent EP-1883885-A2 (EP)
Inventor: JIANG HONG
IPC: G06F15/80
Filed: 2006-05-02
Abstract: An apparatus, system, method, and article for parallel execution of media encoding using single instruction multiple data processing are described. The apparatus may include a media processing node to perform single instruction multiple data processing of macroblock data. The macroblock data may include coefficients for multiple blocks of a macroblock. The media processing node may include an encoding module to generate multiple flag words associated with multiple blocks from the macroblock data and to determine run values for multiple blocks in parallel from the flag words. Other embodiments are described and claimed.
Patent EP-1874300-A2 (EP)
Title: Procede de traitement du syndrome d'apathie
Inventor: CHA ALBERT
IPC: A61K31/4015
Filed: 2006-04-19
Abstract: Cette invention concerne un procédé de traitement du syndrome d'apathie chez un sujet humain. A cet effet, le sujet humain est d'abord évalué pour déterminer si une ou plusieurs caractéristiques comportementales d'apathie sont observées. Si de telles caractéristiques sont observées, le sujet est traité avec un composé de 2-oxopyrrolidine, tel que nefiracetam, piracetam, aniracetam, pramiracetam, nebracetam, fasoracetam, levetiracetam ou oxiracetam, selon une quantité suffisante pour produire une amélioration de ces caractéristiques d'apathie. Cette invention sert à traiter l'apathie chez un sujet souffrant d'états associés à un dysfonctionnement fronto-sous-cortical ou se caractérisant par un tel dysfonctionnement fronto-sous-cortical. Cette invention sert également à traiter l'apathie chez un sujet souffrant d'un ictus, de la malaide d'Alzheimer, de la maladie de Parkinson, d'une lésion traumatique du cerveau, de dépression, de schizophrénie, d'une infection à l'hépatite C chronique ou d'une infection à VIH.
Patent EP-1962820-A2 (EP)
Inventor: D ORAZIO DANIEL
IPC: A23L33/20
Filed: 2006-06-23
Abstract: La présente invention concerne des composés représentés par la formule (I); dans laquelle R3 est C1-6-alkyloxy, C1-6-acyloxy ou aroyloxy; R6 est hydrogène ou C1-6-alkyloxy; R7 est C1-6-alkyloxy,C1-6-acyloxy, aroyloxy or arylacyloxy; R8 est hydrogène ou C1-6-alkyloxy; ou R7 et R8 forment ensemble un groupe O-L-O avec L étant (CR1R2)n, avec R1 et R2 étant indépendamment l'un de l'autre hydrogène ou C1-5-alkyle et n étant un entier compris entre 1 et 3; R10 est hydrogène ou N-C1-4-acyle, N-C1-5-alkyl-x-Cx-alkyle avec x étant un entier compris entre 1 et 5, utilisés comme médicaments destinés au traitement d'une pathologie liée à une altération fonctionnelle du métabolisme du glucose et de l'action de l'insuline telles que le syndrome X et le diabète de type 1 et 2, en particulier pour le traitement de diabète de type 2 (non auto-immune). Cette invention concernent aussi des compositions alimentaire telles que des aliments (fortifiés), des boissons, des aliments pour animaux (fortifiés), des additifs alimentaires, des additives de boisson, des additifs d'aliments pour animaux, une nutrition clinique, des suppléments alimentaires, des aliments fonctionnels, des aliments pour animaux fonctionnels et des compositions  neutraceutiques et pharmaceutique contenant ces composés, des procédés de traitement d'une pathologie liée à une altération fonctionnelle du métabolisme du glucose et de l'action de l'insuline chez les mammifères, notamment des humains et les composés représentés par la formule (i) eux-mêmes. Cette invention concerne aussi l'utilisation de ces composés pour la fabrication d'une composition destinée au traitement d'une pathologie liée à une altération fonctionnelle du métabolisme du glucose et de l'action de l'insuline.
Patent EP-1915774-A2 (EP)
Inventor: NUZZO RALPH G
IPC: H05K3/36
Filed: 2006-06-01
Abstract: The present invention provides a high yield pathway for the fabrication, transfer and assembly of high quality printable semiconductor elements having selected physical dimensions, shapes, compositions and spatial orientations. The compositions and methods of the present invention provide high precision registered transfer and integration of arrays of microsized and/or nanosized semiconductor structures onto substrates, including large area substrates and/or flexible substrates. In addition, the present invention provides methods of making printable semiconductor elements from low cost bulk materials, such as bulk silicon wafers, and smart-materials processing strategies that enable a versatile and commercially attractive printing-based fabrication platform for making a broad range of functional semiconductor devices.
Patent EP-1894175-A2 (EP)
Inventor: TICE LEE D
IPC: A61B5/00
Filed: 2006-06-09
Abstract: A residential monitoring system (10) incorporates both physiological sensors (Sl-SN) and activity sensors ((12a-12f). Some of the sensors (Sl-SN) can be in wireless communication with control circuitry (20). One or more activity profiles can be established for resident to expand upon and supplement information from the physiological sensors.
Patent EP-1910473-A2 (EP)
Inventor: NUSSER RAINER
IPC: C09B67/22
Filed: 2006-07-17
Abstract: The present invention relates to novel 1:2 chromium complex dyes, processes for their preparation and their use for dyeing or printing fibre materials containing hydroxyl groups or containing nitrogen. The present invention relates to a 1:2 chromium complex dye of formula (I) wherein all substituents are as defined in the claims, a process for their preparation and their use for dyeing or printing fiber materials containing hydroxyl groups or containing nitrogen.
Patent EP-1899347-A2 (EP)
Inventor: MASTALERZ HAROLD
IPC: C07D487/04
Filed: 2006-06-29
Abstract: Described herein is at least one pyrrolo[1,2-f][1,2,4]triazine-2,4(1H,3H)-dione, which is an intermediates useful in preparing 2,4-disubstituted pyrrolotriazine compounds, and at least one method for making such intermediate.
Patent EP-1915651-A2 (EP)
Inventor: JOHNSON JAMES H JR
IPC: B65D79/00
Filed: 2006-07-24
Abstract: Le procédé de service communautaire selon l’invention comporte les étapes d’établissement d’un réseau de structures possédant des ressources de secours en cas d’urgence en prévention d’une catastrophe possible, d'équipement de ces structures en dispositifs d’affichage électroniques et d’affichage d’un message d’urgence sur les dispositifs d’affichage électroniques lorsqu'une catastrophe se produit.
Patent EP-1940404-A2 (EP)
Inventor: CECI ANGELO
IPC: A61P15/00
Filed: 2006-07-06
Abstract: L'invention concerne l'utilisation d'un inhibiteur de recaptage du neurotransmetteur monoamine, cet inhibiteur comprenant une fraction tropane 2,3-disubstituée, ou un tautomère, un sel acceptable d'un point de vue pharmaceutique, un solvate ou un dérivé fonctionnel d'un point de vue physiologique de celui-ci. Cet inhibiteur est utilisé dans la fabrication d'un médicament pour traiter les troubles de la libido.
Patent EP-1929649-A2 (EP)
Title: Procede et dispositif de suppression des interferences
Inventor: WANG SHU
IPC: H04B1/10
Filed: 2006-09-26
Abstract: Cette invention concerne un procédé d'atténuation des interférences dans un système de communication sans fil. Plus précisément, ce procédé englobe les opérations suivantes: réception d'au moins deux signaux depuis une pluralité d'extrémités d'émission; estimation de la valeur d'interférence en fonction d'un nombre prédéterminé de signaux reçus et d'un signal actuel; suppression de l'interférence des signaux reçus au moyen de la valeur d'interférence estimée; et obtention de l'information souhaitée du signal reçu et débarrassé de l'interférence.
Patent EP-1948475-A2 (EP)
Title: Systeme d'airbag, siege de vehicule equipe d'un systeme d'airbag et procede de declenchement d'un systeme d'airbag
Inventor: MUELLER HELMUT
IPC: B60N2/90
Filed: 2006-10-12
Abstract: L'invention concerne un système d'airbag dans lequel un système d'ouverture intégré est en même temps fixé automatiquement au module d'airbag, un siège de véhicule équipé d'un tel système d'airbag ainsi qu'un procédé de déclenchement d'un système d'airbag de ce type.
Patent EP-1941377-A2 (EP)
Title: Teilnehmerschnittstelle zwischen einem mikrocontroller und einem flexray-kommunikationsbaustein, flexray-teilnehmer und verfahren zur übertragung von botschaften über eine solche schnittstelle
Inventor: NEWALD JOSEF
IPC: G06F13/28
Filed: 2006-10-05
Abstract: Die Erfindung betrifft eine Teilnehmerschnittstelle (107) zwischen einem FlexRay-Kommunikationsbaustein (100), der an eine FlexRay-Kommunikationsverbindung (101) angeschlossen ist, über welche Botschaften übertragen werden, und der einen Botschaftsspeicher (300) zum Zwischenspeichern von Botschaften von der FlexRay-Kommunikationsverbindung (101) oder für die FlexRay-Kommunikationsverbindung (101) umfasst, und einem dem FlexRay-Kommunikationsbaustein (100) zugeordneten Mikrocontroller (102), der einen Mikroprozessor (811) und einen Direct-Memory-Access (DMA) Controller (812) für einen Datenaustausch mit dem Botschaftsspeicher (300) aufweist. Um den DMA-Controller (812) des Mikrocontrollers (102) besser an den FlexRay-Kommunikationsbaustein (100) anzubinden, wird vorgeschlagen, dass die Teilnehmerschnittstelle (107) eine Zustandsmaschine (800) aufweist, welche nach Konfiguration durch den Mikroprozessor (811) des Mikrocontrollers (102) eine Datenübertragung zwischen dem Botschaftsspeicher (300) des FlexRay-Kommunikationsbausteins (100) und dem DMA-Controller (812) selbständig koordiniert und steuert.
Patent EP-1808272-A2 (EP)
Inventor: IKUTA HIROKI
IPC: B25B23/14
Filed: 2007-01-10
Abstract: It is an object of the invention to provide an effective technique for improving the durability of a torque limiter utilized in a power tool. The object is achieved by a representative power tool (101) comprising a tool bit (119), a driving mechanism and a torque limiter (151). The torque limiter (151) includes first and second rotating members, a ball (155), a pressing member and an elastic member (159). The second rotating member includes a power transmitting region with a groove continuously formed from a deepest groove part to a shallowest groove part to allow torque transmission and a power transmission interrupted region with a groove shallower than the shallowest groove part of the power transmitting region to interrupts the torque transmission. According to this construction, when the ball (155) is in the power transmitting region, the pressing member contacts the first rotating member and is held in a position in which the biasing force of the elastic member (159) is prevented from acting upon the ball.